Wedbush Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $40
Portfolio Pulse from richadhand@benzinga.com
Wedbush analyst Robert Driscoll maintains an Outperform rating on IDEAYA Biosciences (NASDAQ:IDYA) and raises the price target from $35 to $40.
August 11, 2023 | 2:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst maintains Outperform rating on IDEAYA Biosciences and raises the price target from $35 to $40.
The news is directly about IDEAYA Biosciences and is likely to have a positive impact on the stock in the short term. The Outperform rating indicates that the analyst expects the stock to do better than the market average. The increase in price target from $35 to $40 suggests that the analyst sees more upside potential in the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100